Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia.
Cimino G, Lo-Coco F, Fenu S, Travaglini L, Finolezzi E, Mancini M, Nanni M, Careddu A, Fazi F, Padula F, Fiorini R, Spiriti MA, Petti MC, Venditti A, Amadori S, Mandelli F, Pelicci PG, Nervi C.
Cimino G, et al.
Cancer Res. 2006 Sep 1;66(17):8903-11. doi: 10.1158/0008-5472.CAN-05-2726.
Cancer Res. 2006.
PMID: 16951208